Evidence map›Paper›PMID 19571798›Full record

ArticleMucosal immunology2009

Suppression of Th1 and Th17, but not Th2, responses in a CD8(+) T cell-mediated model of oral tolerance.

P M Arnaboldi, F Roth-Walter, L Mayer

Open access · bronzeAbstract read
In one paragraph

Article in Mucosal immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. New Insights on CD8Frontiers in immunology · 2021
    Review
  3. Role of Regulatory Cells in Oral Tolerance.Allergy, asthma & immunology research · 2017
    Review
  4. Article
  5. Review
  6. Mucosal immunology of food allergy.Current biology : CB · 2013
    Review
  7. Engineering antigens for in situ erythrocyte binding induces T-cell deletion.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  8. Can we produce true tolerance in patients with food allergy?The Journal of allergy and clinical immunology · 2013
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

P M ArnaboldiImmunology Institute, The Mount Sinai School of Medicine, New York, New York, USA.
F Roth-Walter
L Mayer
Icahn School of Medicine at Mount Sinai · USMedical University of Vienna · AT

Funding

Mechanistic CoreU19AI066738 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SAMPSON, HUGH A · 2005 to 2016
$43.6M
Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
THE ROLE OF ICSBP IN MUCOSAL IMMUNE RESPONSEP01DK072201 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HARPAZ, NOAM · 2006 to 2015
$14.6M
Tolerance vs. Allergenicity; Factors Dictating Differing ResponsesU19AI044236 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAMPSON, HUGH A · 2008 to 2014
$9.8M
ORAL TOLERANCE AND COW MILK ALLERGYP01AI044236 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SAMPSON, HUGH · 1999 to 2007
$7.5M
TRAINING PROGRAM IN INVESTIGATIVE GASTROENTEROLOGYT32DK007792 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CHO, JUDY H. · 2001 to 2016
$2.3M
Oral Vaccine Platform for Yersinia pestisR01AI084952 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DATTWYLER, RAYMOND JAMES, MAYER, LLOYD F · 2010 to 2012
$1.2M
The Role of CD8+ cells in the Development of Oral ToleranceF32AI074269 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARNABOLDI, PAUL MICHAEL · 2009 to 2010
$106k
Austrian Science Fund FWF J 2614NIAID NIH HHS AI 044236NIAID NIH HHS AI 061093NIAID NIH HHS AI 084952NIAID NIH HHS F32 AI074269NIAID NIH HHS P01 AI044236NIAID NIH HHS U19 AI044236NIAID NIH HHS U19 AI066738NIDDK NIH HHS DK 072201NIDDK NIH HHS P01 DK072201NIDDK NIH HHS T32 DK007792
6 · The paper itself

Abstract

The role of CD8(+) T cells in oral tolerance remains unclear. To address this, we developed a model to induce CD8(+) Tregs by feeding the major histocompatibility complex class I immunodominant epitope of OVA, OVA((257-264)). OVA((257-264)) feeding induced tolerance similar to that observed in OVA protein-fed mice, capable of suppressing the production of Th1 and Th17 cytokines and inhibiting a Th1-driven delayed-type hypersensitivity response following immunization with whole OVA (wOVA) protein. OVA((257-264)) peptide-induced suppression could be transferred to naive mice with CD8(+) cells, but not CD8-depleted cells, isolated from mesenteric lymph nodes of peptide-fed mice. Interestingly, while capable of inhibiting Th1 and Th17 responses, OVA((257-264)) feeding could not suppress any feature of a Th2 inflammatory response, though OVA protein feeding could, suggesting that these cells function through a different mechanism than their CD4(+) counterparts generated in response to feeding with wOVA. Thus, CD8(+) T cells are functionally capable of mediating tolerance to Th1 and Th17 responses.

Indexed as

Administration, IntranasalAdministration, OralAdoptive TransferAlveolitis, Extrinsic AllergicAnimalsAntigensCD8-Positive T-LymphocytesDesensitization, ImmunologicEar, ExternalEdemaImmune ToleranceImmunizationImmunodominant EpitopesInjections, IntradermalLymphocyte CooperationMiceAntigensImmunodominant EpitopesOVA-8OvalbuminPeptide Fragments

Identifiers

PMID19571798
PMCPMC2857757
OpenAlexW1963481034

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.